Background and Aims: Genome-wide association studies of inflammatory bowel disease identified > 200 susceptibility loci only in autosomes. This study aimed to identify inflammatory bowel disease susceptibility loci on the X chromosome. Methods: We performed an X chromosome-wide association study in Korean patients with inflammatory bowel disease. We analysed X chromosome data from our recent genome-wide association studies, including 1505 cases [922 Crohn's disease and 583 ulcerative colitis] and 4041 controls during the discovery phase, followed by replication in additional 1989 cases [993 Crohn's disease, 996 ulcerative colitis] and 3491 controls. Sex-related differential effects of single nucleotide polymorphisms on disease were also evaluated. Results: We confirmed a significant association of a previously reported inflammatory bowel disease susceptibility locus at chromosome Xq26.3 [CD40LG-ARHGEF6; odds ratio, 1.22; 95% confidence interval, 1.16-1.28; combined p = 3.79 × 10
Introduction
Over the past decade, genome-wide association studies [GWASs] have identified > 200 susceptibility loci for inflammatory bowel disease [IBD] , thereby providing insights into IBD pathogenesis. 1, 2 However, the role of the X chromosome in IBD remains largely unknown because the largest meta-analyses involving GWAS and Immunochip data from 96 486 individuals of various ancestries, as well as a trans-ethnic association study, omitted the X chromosome from analysis. 1, 2 Previous studies suggested that the X chromosome contributes to IBD risk, [3] [4] [5] particularly in early onset cases. 6, 7 However, the X chromosome has been neglected in most GWAS, given the lack of toolsets specially designed for X chromosome analysis. 8, 9 Females possess two copies of the X chromosomes, whereas males possess one X and one Y chromosome. Early in embryonic development, long segments of one of the two female X chromosome copies are transcriptionally silenced through a process known as X-chromosome inactivation [XCI] to achieve dosage compensation of X-linked genes in males and females. 10 In general, the XCI process is random; approximately half of the cells in a female contain an active form of one copy, whereas the remaining cells have an active form of the other copy. However, skewed or nonrandom XCI occurs when the inactivation of one X chromosome is favoured over the other, leading to uneven numbers of cells with each chromosome inactivated. A skewed XCI is defined as the identification of a single allele on the active X chromosome in over 75% of cells. 11, 12 In skewed XCI, we cannot assume that the genotypic effects for heterozygous females will represent the midpoint between two homozygous genotypes; therefore, special consideration is required. 11, 13 Another complexity of X chromosome data analysis is the presence of pseudoautosomal regions on the X chromosome, where genes escape XCI and are inherited similarly to autosomal genes. 14, 15 In addition, the lack of coverage on GWAS chips further impedes X chromosome association studies. 8, 9 However, various quality control and analytical tools specially designed for X chromosome data have recently become available. 13, 16 X chromosome-wide association studies have been reported for other diseases and traits. [17] [18] [19] A previously reported meta-analysis of paediatric-onset IBD identified genomewide significant loci on the X chromosome. 20 However, GWASs to identify X chromosome susceptibility loci in adult patients with IBD are limited.
Recent studies from Korea, China, and Japan have consistently reported a male predominance of Crohn's disease [CD] among Asian patients with CD, [21] [22] [23] [24] whereas studies from Western countries report an equal ratio or slight shift toward female predominance. 25 However, Asian GWASs of CD have seldom included the X chromosome 26, 27 or did not identify any loci on the X chromosome at a genome-wide significance level. 28, 29 An analysis of the X chromosome in an Asian CD GWAS dataset might help in explaining the male predominance of CD in Asian patients. Hence, we performed an X chromosome-wide association study with the intent to identify new IBD susceptibility loci in a well-defined, hospitalbased cohort.
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Materials and Methods
Study population
A total of 3494 patients with IBD [CD, 1915; ulcerative colitis [UC] , 1579] who were undergoing treatment at Asan Medical Center, Seoul, Korea, and 7532 healthy controls were included. CD and UC diagnoses were based on clinical, radiological, endoscopic, and histopathological criteria. 21 Clinical characteristics of the study subjects are shown in Table 1 . All study subjects were of Korean descent, and the demographic and clinical characteristics of the discovery and replication cohorts did not indicate significant differences.
The discovery cohort comprised 1505 patients with IBD, including 922 and 583 with CD and UC, respectively, as well as 4041 healthy controls. We combined data from 915 individuals with IBD [CD, 532; UC, 383] and 745 healthy controls included in our previously published GWAS, 29, 31 with additional data of 590 individuals with IBD [CD, 390; UC, 200] and 3296 population controls from the Korea National Institute of Health, to increase the power of our GWAS-based discovery analysis. 27 The 
Genotyping and quality control
Details of the discovery GWAS panels and an independent replication panel, as well as the genotyping platforms used, are provided in Supplementary Table 1 , available as Supplementary data at ECCO-JCC online. In our previously published GWAS, 29, 31 IBD cases were genotyped using Illumina OmniExpress arrays; newly included IBD cases were genotyped using Illumina OmniExpressExome arrays. 27 All controls were genotyped using Illumina Omni1-Quad arrays. After quality filtering the samples as described in our previous study, 27 1505 individuals with IBD [CD, 922; UC, 583] and 4041 healthy controls were combined and enrolled as the discovery cohort. The results of the quantile-quantile p-value plots are presented in Supplementary Figure 1 , available as Supplementary data at ECCO-JCC online.
Single nucleotide polymorphism [SNP] quality control was ensured using an integrated approach. Some quality control steps were specific to the X chromosome [Supplementary ]. X-specific quality control steps included filtering SNPs with significant deviations from the Hardy-Weinberg equilibrium in females [p < 1.0 × 10 −4 ], significantly different MAFs between male and female controls [p < 1.0 × 10 −7 ], and differential missingness between males and females [p < 1.0 × 10 −7 ]. 9 After these SNP quality control analyses, genotype data of 11 757 SNPs in 1505 cases and 4041 controls remained available for our X chromosome-wide association study.
Association testing
Given the unique nature of the X chromosome, 13, 32, 33 we performed association analyses using PLINK [1.90] and XWAS [1.1] . 16 X chromosome-wide associations were consequently analysed using the following three methods. The first two analyses were implemented in PL INK using the '--xchr-model 2' option depending on the presence and absence of inactivation. Because the true underlying XCI process is unknown and differs among various regions of the X chromosome, unified approaches were undertaken by assuming the occurrence of XCI escape or completeness of random XCI. Females were considered to have 0, 1, or 2 copies of an allele, as in an autosomal analysis.
[1] Assuming no inactivation [escape from XCI], males were considered to have 0 or 1 as a covariate on the X chromosome; this assumed XCI escape but ignored biologically plausible random and skewed XCI mechanisms, with consequent overestimations of odds ratios [ORs]. [2] Assuming inactivation [complete XCI], the test effectively assumed complete and uniform XCI in females and a similar effect size between males and females. In this second test, males were considered to have 0 or 2 copies of the same allele, and hemizygous males were considered equivalent to homozygous females. [3] XWAS 16 implemented sex-stratified analyses or tests separately conducted in males and females and then combined. We noted that the assumptions of complete XCI and equal effect sizes often did not hold. Hence, we performed separate sex-stratified analyses of data from cases and controls of each sex. Subsequently, the female-and male-only measures of significance were combined using Fisher's method and a weighted Stouffer's method [XWAS] . Theses sex-stratified analyses supported the possibility of a differential effect size and direction between males and females and were not affected by allele coding in males. 16, 34 In addition, the Breslow-Day tests were performed to evaluate the significance of heterogeneity between males and females. We present the results of all three analyses and emphasise the results obtained after coding males as either having 0 or 2 copies of an allele [complete XCI].
Association tests were performed using a logistic regression model. A conditional regression analysis was performed to identify possible independent associations of genome-wide significant loci. In addition, as a fine-tuning step to confirm the associations, we applied a linear mixed model approach [GEMMA] 35 to the discovery dataset. We also recalculated combined p-values using weighted z-score strategy. A quantile-quantile plot was generated using R [3.2.0; R Project for Statistical Computing] to evaluate the overall significance of the genome-wide associations and the potential impact of population stratification. The Manhattan plot of −log 10 p was generated using R [3.2.0].
SNP selection for replication and joint analysis
Following the X chromosome-wide discovery analysis of 1505 IBD cases and 4041 controls, SNPs with p-values of < 10 −4 were selected for replication in an independent cohort [Supplementary The final joint analysis of the combined X chromosome-wide association study and replication samples was performed using a fixed-effect meta-analysis model. In the final joint analysis of sexstratified data from the discovery and replication samples, combined p-values were calculated using a weighted z-score strategy. Because three tests were performed, we used a genome-wide significance threshold defined as p < 1. 
Candidate gene prioritisation and functional effects
To annotate the lead SNPs in candidate genes, we prioritised candidate genes based on Hi-C datasets, 36 observed LD blocks, and observed evidence of previous association signals with autoimmune diseases or other immune-related phenotypes as presented in the Ensembl, UCSC Genome Bioinformatics, GeneCards, and GWAS Catalog databases. 37 To infer potential gene targets, we used Hi-C chromatin interaction datasets from GM12878 cells. 36 38 We used GTEx 39 to investigate gene expression within genomic regions of interest.
Imputation
Imputed data were only used to examine association patterns in regional plots of loci identified during the discovery phase. We imputed 5546 samples [1505 IBD cases and 4041 controls] using genotyped SNPs that passed the above-described quality control filter. Imputation was performed using IMPUTE version 2. 40 SNPs with a low imputation quality [posterior probability score, < 80%], MAF of < 1%, missing rate of > 10%, or deviation from Hardy-Weinberg equilibrium in females [p < 1.0 × 10 −4 ] were excluded from further analysis. A total of 152 495 imputed SNPs passed the quality control tests and were combined with 11 757 genotyped SNPs for the association analysis.
Variance
The fraction of genetic variance explained by each risk allele was estimated using an algorithm developed by So et al. 41 and a liability threshold model. This model proposed a latent continuous liability that was assumed to be normally distributed with a mean of 0 and variance of 1. A CD prevalence of 0.0112% and UC prevalence of 0.0309% were assumed in the Korean population. 21 To calculate heritability, explained by a single variant, we used disease prevalence, allele frequency, and OR per allele coding in males (male genotypes were coded as [0,1] and [0,2]) .
Results
Identification of IBD-associated loci on the X chromosome
After applying stringent quality control measures specially designed for the X chromosome, we analysed 11 757 SNPs in 1505 cases and 4041 controls using a logistic regression model. The quantilequantile plots appeared normal, as noted in Supplementary Figure 1 35 the association results did not change much and the significance estimates increased in significance [ Table 2 ]. The regional association of rs2427870 is shown in Figure 2 . Conditional analysis within this locus did not identify additional independent signals. The other candidate SNPs, rs2214421 on CTPS2 and rs5918267 on CASK, were not replicated in the replication cohorts [Supplementary Table 4 , available as Supplementary data at ECCO-JCC online].
Given the location of rs2427870 in the intergenic region, we searched for candidate genes that could potentially be affected by the transcription factor-DNA binding affinity of rs2427870 through an examination of topological domains and Hi-C chromatin interaction data in GM12878 cells [ Supplementary Figure 2A Figure 3 ]. The GWAS Catalog provided earlier evidence of association signals between CD40LG and IBD, 20, 37 whereas ARHGEF6 was previously found to be associated with CD in a gene-based association study. 34 Altogether, both CD40LG and ARHGEF6 are biologically plausible candidates in this locus. Genomic annotation on high LD surrogates [r 2 ≥ 0.8, ASN] of rs2427870 was conducted using HaploReg v1; this indicated possible effects on regulatory motifs only with Regulome DB score 6 [minimal binding evidence; Supplementary Table 5 , available as Supplementary data at ECCO-JCC online]. In a meta-analysis of paediatric age of onset autoimmune diseases, 20 rs2807264, which maps within 70 kbp upstream of CD40LG, was found to be associated with both CD and UC. In our GWAS, although it was imputed data, rs2807264, located 1714 bp away from our top SNP rs2427870 with an r 2 value of 0.532, was replicated [discovery p = 2.84 × 10 −10 ; males coding as 0 or 2]. A reciprocal conditional analysis of rs2807264 and rs2427870 indicates that they might not represent independent signals [Supplementary 
Sex-stratified analysis
To evaluate potential sex-specific effects in the loci with genomewide significance, data from each sex [female-and male-only analyses] were separately analysed using XWAS. 16 In these sex-stratified analyses, no significant differences in the effect sizes of rs2427870 were observed for IBD overall or for CD and UC separately [measured by OR; Table 3 ], and heterogeneity was not observed between females and males [p BD > 0.10; Table 3 ]. The joint rs2427870 metaanalysis of the discovery and replication samples, which used a weighted z-score strategy for each Fisher's test result and a weighted Stouffer's method, consistently demonstrated genome-wide significance at a threshold of p < 1.67 × 10 −8 [meta-combined Fisher p = 1.15 × 10 −13 and meta-combined Stouffer p = 7.13 × 10 −14 ].
Explanation of the observed variance
These risk loci on the X chromosome accounted for 0.18% of CD risk and 0.12% of UC genetic risk (male coded [0, 2]; Supplementary Table 7 , available as Supplementary data at ECCO-JCC online) on the basis of CD [0.0112%] and UC [0.0309%] prevalence rates in the Korean population. On the basis of our previous study, which estimated 6.65% of total CD genetic risk and 5.47% of total UC genetic risk from 29 autosomal loci, 27 these 30 loci together explain the 6.83% of variance in CD and 5.59% of total UC genetic risk, respectively.
Discussion
In this first X chromosome-wide association study of adult patients with IBD, we identified an IBD susceptibility locus with genomewide significance at rs2427870 on chrXq26.3, located 66 kbp upstream of CD40LG and 83.4 kbp upstream of ARHGEF6 [OR, 1.22; combined p = 3.79 × 10 −15 ]. Given the complex difficulties associated with X chromosome analysis, these data are collected but seldom analysed. In the present X chromosome-wide association study, rs2427870 on the X chromosome [CD40LG-ARHGEF6] was found to account for 0.18% of CD genetic risk and 0.12% of UC genetic risk in males coded as [0,2] from our Korean population. This finding highlights the need for additional X chromosome-wide association studies of IBD. The combined p-value was calculated using the weighted z-score meta-analysis.
f I 2 and pQ were calculated for estimating heterogeneity.
g p_BD was calculated using the Breslow-Day test for heterogeneous association male and female.
Only one X chromosome-wide association study for IBD has been previously reported. 20 45, 46 CD40LG is mainly expressed on the surfaces of activated CD4+ T-helper cells and platelets but can also be upregulated on the surfaces of other cell types with respect to autoimmune diseases. 46, 47 The CD40-CD40LG interaction activates multiple inflammation-related pathways in both immune and nonimmune cells and is critical for IBD development. 46 Upregulation of both CD40 and CD40LG has been observed in the course of active IBD, particularly within the inflamed mucosa. [42] [43] [44] [45] Altogether, CD40LG on the X chromosome potentially confers susceptibility to IBD in children and adults; therefore, additional X chromosome-wide association studies of adult Caucasian patients with IBD are required.
ARHGEF6 [also called α-PIX, Cool-2] belongs to a family of proteins that act as guanine nucleotide exchange factors toward Rho GTPases and is involved in integrin-mediated signalling that leads to the activation of GTPases Rac1 and/or Cdc42. [48] [49] [50] ARHGEF6 particularly plays roles in immune cells, including neutrophils and T cells. 51, 52 ARHGEF6 [gene-based test, p = 1.67 × 10 −5 ] was associated with IBD and was strongly expressed in T cells [BioGPS] . 8 The persistent inflammatory state in IBD is mediated by the migration of activated T cells from the blood to the intestinal mucosa. Leukocyte infiltration is regulated via interactions with integrins. 53, 54 Recent approaches that involved the targeting of leukocyte homing by blocking the interaction between integrin and/or adhesion molecules and T cells 53, 54 represent an emerging concept in IBD therapy. ARHGEF6 involvement in integrin-mediated signalling further implicates its role in IBD pathogenesis.
CD disproportionately affects male patients in Asia [60%-70% of patients], for poorly understood reasons. [21] [22] [23] [24] Although it is not clear whether differences in disease prevalence by sex are genetic and due to differences in effects conferred by common variants, the X chromosome-wide association study could help in explaining the male predominance among Korean patients with CD. When we performed sex-stratified analyses to test whether differences in the effect size of the top SNP on the X chromosome exist between males and females, we failed to identify any significant sex-specific differences in effect size [ Table 3 ]. This could be due to a small sample size of our study. If the differences in genetic effects between men and women were small, further studies with a larger sample size are warranted to identify genetic evidence underlying the male predominance in East Asian patients with CD.
Our study has some limitations. First, as the smoking histories of the control subjects were unknown, we could not evaluate the effect of smoking as a covariant. Second, the sample size was relatively small in terms of female patients with IBD [529 in the discovery cohort and 714 in the replication cohort], and this might have influenced the results of the study. Third, the potential selection bias of this hospital-based cohort study limits the generalization of our study results, although the demographic characteristics of this study were quite similar to a previous population-based cohort study of IBD conducted in Korea. 21 Finally, the XCI patterns are not yet completely understood, and XCI has been shown to be tissue specific. 15, 55 We evaluated X chromosome-adapted association tests both with and without the assumption of XCI, but did not consider different XCI patterns across different tissues.
An IBD susceptibility locus on the X chromosome [CD40LG-ARHGEF6], rs2427870, was confirmed in our X chromosome-wide association study. This finding increased the total explained genetic variance of CD and UC risks among the Korean population to 6.83% and 5.59%, respectively. Altogether, these data highlight a potential role for the X chromosome in IBD pathogenesis.
